These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 16254611

  • 1. Effect of combined treatment with aspirin and dipyridamole on oxidative homeostasis in mouse serum.
    Ivasenko IN, Dorofeikov VV, Shlyakhto EV.
    Bull Exp Biol Med; 2005 Jul; 140(1):22-4. PubMed ID: 16254611
    [Abstract] [Full Text] [Related]

  • 2. Free radical oxidation and antioxidant activity in blood plasma and myocardium during long-term dipyridamole treatment.
    Ivasenko IN, Shlyakhto EV.
    Bull Exp Biol Med; 2001 Jun; 131(6):538-40. PubMed ID: 11586400
    [Abstract] [Full Text] [Related]

  • 3. Effect of disturbed plasma oxidant homeostasis on hemopoietic differentiation of polypotent bone marrow stem cells in mice treated with dipyridamole.
    Ivasenko IN, Shlyakhto EV.
    Bull Exp Biol Med; 2001 Aug; 132(2):766-8. PubMed ID: 11713561
    [Abstract] [Full Text] [Related]

  • 4. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F, Praticò D, Iuliano L, Balsano F.
    J Lipid Mediat; 1991 Aug; 4(1):61-7. PubMed ID: 1909906
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL, Malinin AI, Sane DC.
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of platelet aggregation in whole blood by dipyridamole and aspirin.
    Heptinstall S, Fox S, Crawford J, Hawkins M.
    Thromb Res; 1986 Apr 15; 42(2):215-23. PubMed ID: 3715801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduced red cell deformability associated with blood flow and platelet activation: improved by dipyridamole alone or combined with aspirin.
    Bozzo J, Hernández MR, Ordinas A.
    Cardiovasc Res; 1995 Nov 15; 30(5):725-30. PubMed ID: 8595619
    [Abstract] [Full Text] [Related]

  • 15. Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
    Joseph R, Welch KM, D'Andrea G.
    Stroke; 1989 May 15; 20(5):609-11. PubMed ID: 2718200
    [Abstract] [Full Text] [Related]

  • 16. Effects of dipyridamole and low-dose aspirin therapy on platelet adhesion to vascular subendothelium.
    Lauri D, Zanetti A, Dejana E, de Gaetano G.
    Am J Cardiol; 1986 Dec 01; 58(13):1261-4. PubMed ID: 3788816
    [Abstract] [Full Text] [Related]

  • 17. Heparin neutralization of antiplatelet effect of aspirin and dipyridamole.
    Mohammad SF, Kim SW, Olsen DB.
    ASAIO Trans; 1988 Dec 01; 34(3):322-7. PubMed ID: 2848561
    [Abstract] [Full Text] [Related]

  • 18. Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers.
    Cox D, Maree AO, Dooley M, Conroy R, Byrne MF, Fitzgerald DJ.
    Stroke; 2006 Aug 01; 37(8):2153-8. PubMed ID: 16794200
    [Abstract] [Full Text] [Related]

  • 19. The effects of aspirin and dipyridamole and its derivatives on platelet disaggregation.
    Morris CD, Heslop PA.
    Cent Afr J Med; 1977 Nov 01; 23(11):251-3. PubMed ID: 603896
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.